ag013
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT00938080)
Timeline
Indications
Studied for
Mechanism of action
- Lactococcus lactisSupplementation
Lactococcus lactis supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ag013
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03234465 | Phase 2 | Jul 18, 2017 | Oragenics, Inc., Sponsor GmbH |
| NCT00938080 | Phase 1 | Sep 1, 2009 | ActoGeniX, Vanderbilt University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ActoGeniX | For profit | 1 | 1 | 1 | 2009 |
| Oragenics, Inc. | For profit | 1 | 1 | 1 | 2017 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1